• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Restenosis (4576)
Event Date 07/12/2021
Event Type  Injury  
Event Description
Synergy china registry.It was reported that unstable angina occurred.In (b)(6) 2020, the subject presented with unstable angina and was referred for cardiac catheterization.The target lesion was located in the proximal left anterior descending artery (lad) extending up to distal lad with 100 % stenosis and was 76 mm long, with a reference vessel diameter of 3.0 mm.The target lesion was treated with pre-dilatation and placement of a 2.50 mm x 38 mm and 3.00 mm x 38 mm synergy stent systems.Following post-dilatation, the residual stenosis was noted to be 0%.Three days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2021, the subject was diagnosed with unstable angina and was hospitalized on the same day for further evaluation and treatment.Three days later, the subject was referred for coronary angiography and revascularization was recommended.On the same day, the 95% stenosis noted in middle lad which had previously placed study device was treated with percutaneous coronary intervention.Post intervention, the residual stenosis was 0%.After two days, the event was considered to be recovered/resolved and the subject was discharged on aspirin and clopidogrel.
 
Manufacturer Narrative
E1: (b)(6).
 
Manufacturer Narrative
B5: describe event or problem: updated with additional information.E1: initial reporter facility name: (b)(6).E1: initial reporter phone: (b)(6).
 
Event Description
Synergy china registry: it was reported that unstable angina occurred.In (b)(6) 2020, the subject presented with unstable angina and was referred for cardiac catheterization.The target lesion was located in the proximal left anterior descending artery (lad) extending up to distal lad with 100 % stenosis and was 76 mm long, with a reference vessel diameter of 3.0 mm.The target lesion was treated with pre-dilatation and placement of a 2.50 mm x 38 mm and 3.00 mm x 38 mm synergy stent systems.Following post-dilatation, the residual stenosis was noted to be 0%.Three days later, the subject was discharged on aspirin and clopidogrel.In (b)(6) 2021, the subject was diagnosed with unstable angina and was hospitalized on the same day for further evaluation and treatment.Three days later, the subject was referred for coronary angiography and revascularization was recommended.On the same day, the 95% stenosis noted in middle lad which had previously placed study device was treated with percutaneous coronary intervention.Post intervention, the residual stenosis was 0%.After two days, the event was considered to be recovered/resolved and the subject was discharged on aspirin and clopidogrel.It was further reported that in (b)(6) 2021, the 95% stenosis noted in proximal lad extended to distal lad which had previously placed study device was treated with percutaneous coronary intervention.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
rachel shields
4100 hamline ave n
arden hills, MN 55112
6512422111
MDR Report Key18538057
MDR Text Key333169376
Report Number2124215-2023-74855
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeCH
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Study,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 02/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date01/05/2022
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0025011786
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/26/2023
Initial Date FDA Received01/18/2024
Supplement Dates Manufacturer Received02/01/2024
Supplement Dates FDA Received02/21/2024
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured01/06/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age59 YR
Patient SexMale
-
-